ATF Revises Rules for Marking Explosive Goods Smoothly
Published Date: 11/28/2025
Notice
Summary
The ATF is updating how they collect info about marking explosive materials and wants your feedback by January 27, 2026. This affects businesses and agencies handling explosives, aiming to make paperwork clearer and easier without extra costs. They’re making sure the rules stay useful and not too time-consuming for everyone involved.
Analyzed Economic Effects
3 provisions identified: 2 benefits, 1 costs, 0 mixed.
Estimated Respondent Count and Reduced Burden
ATF estimates 103 respondents will respond 520 times per year, each response taking about 0.000834 hours (3 seconds), for a total annual burden of 45 hours and an estimated annual cost burden of $0. ATF reports this is a reduction from prior total burden of 895 hours (a decrease of 850 hours) and that the affected licensee/permittee pool fell from 2,066 to 2,054 and further to 103 (5% of registrants who actually mark).
Mandatory Marking of Explosive Materials
If you are a licensee or permittee covered by 27 CFR 555.109, you must mark certain explosives you manufacture or import, plus immediate containers and outside packaging. The markings must be clear and permanent but may be applied by sticky label, marker, or similar methods, and some explosives that are too small, too fluid, or otherwise impossible to mark are excepted.
Consolidation of Manufacturer and Importer Collections
ATF combined two prior information collections (manufacturers and importers) into one ICR under OMB control number 1140-0055 and revised the title so it is not limited to manufacturers. The change is intended to streamline and eliminate redundancies between collections.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Related Federal Register Documents
2026-16981, Application for Relief From Disabilities Imposed by Federal Laws With Respect to the Acquisition, Receipt, Transfer, Shipment, Transportation, or Possession of Firearms
The Department of Justice ("the Department") is implementing criteria to guide determinations for granting relief from disabilities imposed by federal laws with respect to the acquisition, receipt, transfer, shipment, transportation, or possession of firearms. The criteria are designed to ensure that the fundamental right of the people to keep and bear arms is not unduly infringed, that those people granted relief are not likely to act in a manner dangerous to public safety, and that granting such relief would not be contrary to the public interest.
2026-15458, Civil Money Penalty for Actions in Contempt of an Immigration Judge's Proper Exercise of Authority
This notice of proposed rulemaking ("NPRM") would implement a provision of the Immigration and Nationality Act ("INA" or "the Act") that authorizes Immigration Judges, under regulations prescribed by the Attorney General, to sanction by civil money penalty any action (or inaction) in contempt of the proper exercise of their authority by certain individuals. The rule would: define the scope of the contempt authority; provide procedures for contempt findings, penalty determinations, and penalty payment; establish an appellate process; and implement oversight of the use of contempt authority. The rule would also make conforming changes to the grounds for practitioner discipline.
2026-11526, Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 2018: Dispensing and Administering Controlled Substances for Medication-Assisted Treatment
Starting July 9, 2026, new rules make it easier for doctors and pharmacies to provide medicine that helps people recover from opioid addiction. These changes affect healthcare providers by expanding who can give medication-assisted treatment and how pharmacies can deliver these medicines. The goal? Faster, safer access to treatment with clear rules that save time and support recovery.
2026-10128, Revision of Applications for Manufacturing and Procurement Quotas
The DEA wants to update how companies apply for permission to make and buy certain controlled drugs and chemicals. These changes will make the rules clearer, help prevent drug shortages, and ensure enough supply for medical and scientific needs. If you’re a manufacturer or involved in this process, get ready to follow new steps and share your thoughts by July 20, 2026.
2026-09160, Implementing PATRIOT Act Improvements: Contraband Cigarettes and Smokeless Tobacco
Starting June 8, 2026, new rules crack down harder on illegal cigarette and smokeless tobacco sales. The government lowered the amount that counts as smuggling from 60,000 to just 10,000 cigarettes and now includes smokeless tobacco in the crackdown. Sellers and distributors must keep better records and report more info, making it tougher to dodge the law and protect honest businesses.
2026-17025, Agency Information Collection Activities; Proposed eCollection eComments Requested Extension of a Previously Approved Collection Title-STOP Match Calculation Worksheet
The Department of Justice (DOJ), Office on Violence Against Women will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995.
Previous / Next Documents
Previous: 2025-21408, Quartz Surface Products From India and Turkey; Revised Schedule for the Subject Proceeding
The U.S. International Trade Commission is updating the timeline for reviewing quartz surface products from India and Turkey because of a government funding pause. Companies involved and interested parties now have until November 18, 2025, to submit their comments. This change might affect how quickly decisions and any related trade actions happen.
Next: 2025-21411, Grant of Interim Extension of the Term of U.S. Patent No. 8,785,125; the Aptima® HPV Assay With the Panther® System
Gen-Probe Inc. just scored a one-year interim extension on their U.S. Patent for the Aptima® HPV Assay with the Panther® System because FDA approval is still in progress. This means the patent now lasts longer, giving the company more time to protect and profit from their medical device. The extension kicks in right after the original patent expires on December 8, 2025.